Prevention of death from myocardial infarction by aspirin and other platelet active drugs

Clin Cardiol. 1979 Aug;2(4):241-5. doi: 10.1002/clc.4960020402.
No abstract available

Publication types

  • Clinical Trial
  • Editorial

MeSH terms

  • Aspirin / pharmacology
  • Aspirin / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Myocardial Infarction / mortality
  • Myocardial Infarction / prevention & control*
  • Platelet Aggregation / drug effects*
  • Sulfinpyrazone / pharmacology
  • Sulfinpyrazone / therapeutic use*

Substances

  • Aspirin
  • Sulfinpyrazone